| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.78 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |